Doximity (DOCS) EBITDA Margin (2020 - 2026)

Doximity (DOCS) has 7 years of EBITDA Margin data on file, last reported at 17.08% in Q1 2026.

• On a quarterly basis, EBITDA Margin fell 1812.0% year-over-year to 17.08% in Q1 2026; TTM through Mar 2026 was 33.33%, a 661.0% decrease from a year earlier, with the FY2026 full-year figure at 33.33%, down 661.0% from the prior year.
• EBITDA Margin for Q1 2026 stood at 17.08%, down from 38.85% in the prior quarter.
• Over the last five years, EBITDA Margin for DOCS reached as high as 47.4% in Q4 2024 and fell as low as 17.08% in Q1 2026.
• Historically, EBITDA Margin has averaged 33.7% across 5 years, with a median of 35.2% in 2025.
• Across the five-year window, EBITDA Margin jumped 989 bps in 2023 and plunged 1812 bps in 2026, its largest moves.
• Year by year, EBITDA Margin stood at 33.39% in 2022, then climbed by 30 bps to 43.28% in 2023, then advanced by 10 bps to 47.4% in 2024, then decreased by 18 bps to 38.85% in 2025, then plunged by 56 bps to 17.08% in 2026.
• Per Business Quant data, the three most recent EBITDA Margin figures were 17.08% in Q1 2026, 38.85% in Q4 2025, and 37.79% in Q3 2025.